Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Liuying Township, Taiwan Clinical Trials

A listing of Liuying Township, Taiwan clinical trials actively recruiting patients volunteers.

RESULTS

Found (31656) clinical trials

Join us to advance diagnostics for Lyme disease by being in a research study.  If you have been recently diagnosed with Lyme disease or you suspect you have Lyme disease your immune system may hold key information that can help advance development of a novel diagnostic.  Lyme disease is an …

Phase N/A

Migraine pain getting in your way? Consider a clinical research study testing the safety and effectiveness of an investigational drug for migraines. Health insurance is not needed.

Phase N/A

Many migraine sufferers go undiagnosed. Do you have frequent, long headaches with sensitivity to light & sound? Consider a clinical research study testing the safety and effectiveness of an investigational drug for migraines.

Phase N/A

Migraine pain getting in your way? Pharmacology Research Institute is enrolling participants in a clinical research study.  

Phase N/A

Currently, there is no approved vaccine for COVID-19, the illness caused by the novel coronavirus. A research study is evaluating investigational vaccines to see if they could protect against COVID-19.  

Phase N/A

We have several COVID-19 studies enrolling at Medical Center for Clinical Research, looking at COVID-19 tests, vaccines and treatment. Help move COVID-19 research forward by enrolling in a research study today.

Phase N/A

We have several COVID-19 studies enrolling at ClinSearch, looking at COVID-19 tests, vaccines and treatment. Help move COVID-19 research forward by enrolling in a research study today.

Phase N/A

We have several COVID-19 studies enrolling at Clinical Research Center of Nevada, looking at COVID-19 tests, vaccines and treatment. Help move COVID-19 research forward by enrolling in a research study today.

Phase N/A

This study will enroll approximately 800 patients with moderate to severe COPD in 2 subsets. The 24-week subset will enroll approximately 400 patients randomized 1:1 ensifentrine (3 mg): placebo and the 48-week subset will enroll approximately 400 patients randomized 3:1 in order to minimize the number of patients assigned to …

Phase N/A